Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Medical philanthropy pays dividendsEMBO reports, 2019-05, Vol.20 (5), p.n/a [Peer Reviewed Journal]2019 The Author ;2019 EMBO ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201948173Full text available |
|
2 |
Material Type: Article
|
Reframing the "Cancer Moonshot"EMBO reports, 2016-12, Vol.17 (12), p.1685-1687 [Peer Reviewed Journal]2016 The Author ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201643467 ;CODEN: ERMEAXFull text available |
|
3 |
Material Type: Article
|
“Be sustainable”: EOSC‐Life recommendations for implementation of FAIR principles in life science data handlingThe EMBO journal, 2023-12, Vol.42 (23), p.e115008-e115008 [Peer Reviewed Journal]2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2023115008 ;PMID: 37964598Full text available |
|
4 |
Material Type: Article
|
Rethinking research reproducibilityThe EMBO journal, 2019-01, Vol.38 (2), p.n/a [Peer Reviewed Journal]2018 The Author ;2019 EMBO ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2018101117 ;PMID: 30518534Full text available |
|
5 |
Material Type: Article
|
The ethics of animal research. Talking Point on the use of animals in scientific researchEMBO reports, 2007-06, Vol.8 (6), p.526-530 [Peer Reviewed Journal]Copyright © 2007, European Molecular Biology Organization 2007 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.1038/sj.embor.7400993 ;PMID: 17545991 ;CODEN: ERMEAXFull text available |
|
6 |
Material Type: Article
|
Why control an experiment?EMBO reports, 2019-10, Vol.20 (10), p.n/a [Peer Reviewed Journal]2019 The Authors ;2019 EMBO ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201949110Full text available |
|
7 |
Material Type: Article
|
Xenograft and organoid model systems in cancer researchThe EMBO journal, 2019-08, Vol.38 (15), p.e101654-n/a [Peer Reviewed Journal]2019 The Authors. Published under the terms of the CC BY 4.0 license ;2019 The Authors. Published under the terms of the CC BY 4.0 license. ;2019 EMBO ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.2019101654 ;PMID: 31282586Full text available |
|
8 |
Material Type: Article
|
The extracellular matrix modulates the hallmarks of cancerEMBO reports, 2014-12, Vol.15 (12), p.1243-1253 [Peer Reviewed Journal]2014 The Authors ;2014 The Authors. ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439246 ;PMID: 25381661 ;CODEN: ERMEAXFull text available |
|
9 |
Material Type: Article
|
A new pathway for mitochondrial quality control: mitochondrial-derived vesiclesThe EMBO journal, 2014-10, Vol.33 (19), p.2142-2156 [Peer Reviewed Journal]2014 The Authors ;2014 The Authors. ;2014 The Authors 2014 ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.201488104 ;PMID: 25107473 ;CODEN: EMJODGFull text available |
|
10 |
Material Type: Article
|
Exosomes and other extracellular vesicles in host-pathogen interactionsEMBO reports, 2015-01, Vol.16 (1), p.24-43 [Peer Reviewed Journal]2014 The Authors ;2014 The Authors. ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439363 ;PMID: 25488940 ;CODEN: ERMEAXFull text available |
|
11 |
Material Type: Article
|
Where does public funding for cancer research goEMBO reports, 2018-03, Vol.19 (3), p.n/a [Peer Reviewed Journal]2018 The Author ;2018 EMBO ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201845859Full text available |
|
12 |
Material Type: Article
|
The steps from translatable to translational researchEMBO reports, 2014-11, Vol.15 (11), p.1107-1108 [Peer Reviewed Journal]2014 The Author ;2014 The Author 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201439587 ;PMID: 25296643 ;CODEN: ERMEAXFull text available |
|
13 |
Material Type: Article
|
The troubles with peer review for allocating research fundingEMBO reports, 2019-12, Vol.20 (12), p.n/a [Peer Reviewed Journal]2019 The Author. Published under the terms of the CC BY 4.0 license ;2019 EMBO ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.15252/embr.201949472Full text available |
|
14 |
Material Type: Article
|
Aberrant methylation of tRNAs links cellular stress to neuro-developmental disordersThe EMBO journal, 2014-09, Vol.33 (18), p.2020-2039 [Peer Reviewed Journal]2014 The Authors. Published under the terms of the CC BY 4.0 license ;2014 The Authors. Published under the terms of the CC BY 4.0 license. ;2014 The Authors. Published under the terms of the CC BY 4.0 license 2014 ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.15252/embj.201489282 ;PMID: 25063673 ;CODEN: EMJODGFull text available |
|
15 |
Material Type: Article
|
Targeting senescent cells in translational medicineEMBO molecular medicine, 2019-12, Vol.11 (12), p.e10234-n/a [Peer Reviewed Journal]2019 The Authors. Published under the terms of the CC BY 4.0 license ;2019 The Authors. Published under the terms of the CC BY 4.0 license. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201810234 ;PMID: 31746100Full text available |
|
16 |
Material Type: Article
|
Genetically engineered mouse models in oncology research and cancer medicineEMBO molecular medicine, 2017-02, Vol.9 (2), p.137-153 [Peer Reviewed Journal]2016 The Authors. Published under the terms of the CC BY 4.0 license ;2016 The Authors. Published under the terms of the CC BY 4.0 license. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201606857 ;PMID: 28028012Full text available |
|
17 |
Material Type: Article
|
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database AnalysisThe oncologist (Dayton, Ohio), 2022-07, Vol.27 (7), p.573-578 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac049 ;PMID: 35348774Full text available |
|
18 |
Material Type: Article
|
External validity in translational biomedicine: understanding the conditions enabling the cause to have an effectEMBO molecular medicine, 2022-02, Vol.14 (2), p.e14334-n/a [Peer Reviewed Journal]2021 The Authors. Published under the terms of the CC BY 4.0 license ;2021 The Authors. Published under the terms of the CC BY 4.0 license. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.202114334 ;PMID: 34927359Full text available |
|
19 |
Material Type: Article
|
Dedifferentiation and reprogramming: origins of cancer stem cellsEMBO reports, 2014-03, Vol.15 (3), p.244-253 [Peer Reviewed Journal]2014 The Authors ;2014 The Authors 2014 ;ISSN: 1469-221X ;EISSN: 1469-3178 ;DOI: 10.1002/embr.201338254 ;PMID: 24531722 ;CODEN: ERMEAXFull text available |
|
20 |
Material Type: Article
|
Rapid Implementation of Telemedicine During the COVID‐19 Pandemic: Perspectives and Preferences of Patients with CancerThe oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.e679-e685 [Peer Reviewed Journal]2021 AlphaMed Press ;2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13676 ;PMID: 33453121Full text available |